Capital International Investors’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,089,179
Closed -$81.9M 461
2024
Q3
$81.9M Sell
2,089,179
-1,115,288
-35% -$40.3M 0.02% 293
2024
Q2
$103M Buy
3,204,467
+117,510
+4% +$3.79M 0.02% 263
2024
Q1
$102M Buy
3,086,957
+1,053,236
+52% +$36.6M 0.02% 274
2023
Q4
$70.6M Buy
2,033,721
+50,429
+3% +$1.74M 0.02% 303
2023
Q3
$71.8M Sell
1,983,292
-2,720,073
-58% -$101M 0.02% 295
2023
Q2
$177M Sell
4,703,365
-1,928,555
-29% -$77.6M 0.04% 244
2023
Q1
$307M Buy
6,631,920
+240,877
+4% +$11.2M 0.08% 198
2022
Q4
$296M Buy
6,391,043
+1,871,400
+41% +$85.1M 0.08% 210
2022
Q3
$198M Buy
4,519,643
+532,046
+13% +$24.5M 0.06% 240
2022
Q2
$169M Buy
3,987,597
+24,368
+0.6% +$1.03M 0.05% 254
2022
Q1
$172M Buy
3,963,229
+1,999,617
+102% +$92.7M 0.04% 264
2021
Q4
$104M Buy
1,963,612
+1,030,612
+110% +$51.9M 0.02% 311
2021
Q3
$44.3M Hold
933,000
0.01% 357
2021
Q2
$42.4M Hold
933,000
0.01% 373
2021
Q1
$40M Buy
+933,000
New +$38.7M 0.01% 357

Other funds holding G

Capital International Investors's G Position: Q4 2024 in Review

Capital International Investors sold out of Genpact (G) in Q4 2024, closing a stake of 2,089,179 shares — an estimated $81.9M sold.

Capital International Investors first reported a position in G in Q1 2021 and held it in 15 quarters. The position peaked at $307M in Q1 2023. 421 funds tracked by Wall St. Rank hold G as of Q4 2024.

  • Capital International Investors reported no remaining Genpact position as of Q4 2024 after selling out during the quarter.
  • Capital International Investors sold 2,089,179 Genpact shares in Q4 2024, an estimated $81.9M.
  • Capital International Investors first reported a position in Genpact in Q1 2021 and held it in 15 quarters.
  • Capital International Investors's Genpact position peaked at $307M in Q1 2023.
  • 421 funds tracked by Wall St. Rank held Genpact as of Q4 2024.

Based on Capital International Investors's 13F filing for Q4 2024, filed 13 Feb 2025.